{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:36Z","timestamp":1786119276108,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/aog.0b013e3181a1d478","type":"journal-article","created":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T03:28:40Z","timestamp":1247714920000},"page":"451-452","source":"Crossref","is-referenced-by-count":34,"title":["Irinotecan Use During Pregnancy"],"prefix":"10.1097","volume":"114","author":[{"given":"Justin","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adanna","family":"Amanze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Di Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Verschraegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210126","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ctrv.2008.01.002","article-title":"Cancer in pregnancy: gaps, challenges and solutions.","volume":"34","author":"Pereg","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"R2-15-20210126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","article-title":"Use of chemotherapy during human pregnancy.","volume":"5","author":"Cardonick","year":"2004","journal-title":"Lancet Oncol"},{"key":"R3-15-20210126","first-page":"39","article-title":"Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update.","volume":"24","author":"Baker","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"R4-15-20210126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ogc.2005.08.003","article-title":"Malignant adnexal masses in pregnancy.","volume":"32","author":"Sayar","year":"2005","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R5-15-20210126","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer: Irinotecan Study Group.","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"R6-15-20210126","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial [published erratum appears in Lancet 2000;355:1372].","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"key":"R7-15-20210126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0889-8588(05)70153-2","article-title":"Topoisomerase-I inhibitors in gynecologic tumors.","volume":"13","author":"Haluska","year":"1999","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200908001-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:17Z","timestamp":1786038917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200908001-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181a1d478","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}